Anita Fejfar-Posevitz
Muenster, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Evaluation of therapy satisfaction with cladribine tablets in patients with RMS: Final results of the non-interventional study CLEVER.
Journal: Multiple sclerosis and related disorders
Published: February 02, 2024
Distinct pattern of lesion distribution in multiple sclerosis is associated with different circulating T-helper and helper-like innate lymphoid cell subsets.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: August 03, 2016
Impaired NK-mediated regulation of T-cell activity in multiple sclerosis is reconstituted by IL-2 receptor modulation.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: May 11, 2016
PML risk stratification using anti-JCV antibody index and L-selectin.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: July 18, 2015
Dimethyl fumarate treatment alters circulating T helper cell subsets in multiple sclerosis.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: July 14, 2015
Assessment of immune functions and MRI disease activity in relapsing-remitting multiple sclerosis patients switching from natalizumab to fingolimod (ToFingo-Successor).
Journal: BMC neurology
Published: May 07, 2015
Effects of blood transportation on human peripheral mononuclear cell yield, phenotype and function: implications for immune cell biobanking.
Journal: PloS one
Published: June 16, 2014
Fingolimod treatment promotes regulatory phenotype and function of B cells.
Journal: Annals of clinical and translational neurology
Published: June 03, 2014
The neuroinflammation biobank in the Department of Neurology, University Hospital Muenster, Germany.
The neuroinflammation biobank in the Department of Neurology, University Hospital Muenster, Germany.
Journal: Biopreservation and biobanking
Published: March 14, 2014
L-selectin is a possible biomarker for individual PML risk in natalizumab-treated MS patients.
Journal: Neurology
Published: August 09, 2013
An assay to quantify species-specific anti-JC virus antibody levels in MS patients.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: February 08, 2013
Anti-JC-virus antibody prevalence in a German MS cohort.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: June 29, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026